Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study
2019 ◽
Vol 13
(2)
◽
pp. 337-344
◽
2020 ◽
Vol 83
(6)
◽
pp. AB159